Clostridium difficile: A reemerging pathogen

Geriatrics

Volumn 63, Issue 9, 2008, Pages

  Calfee, David P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Epidemiology; Prevention; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; COLESTYRAMINE; GLUTAMATE DEHYDROGENASE; IMMUNOGLOBULIN; METRONIDAZOLE; MONOCLONAL ANTIBODY; NITAZOXANIDE; PROBIOTIC AGENT; RAMOPLANIN; RIFAMYCIN; RIFAXIMIN; TOLEVAMER; VANCOMYCIN;

BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; DRUG COST; DRUG INDICATION; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; HAND WASHING; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INFECTIOUS DIARRHEA; PREVALENCE; REVIEW; RISK FACTOR; AGED; COMMUNICABLE DISEASE; CROSS INFECTION; INFECTION CONTROL; METHODOLOGY; PATHOGENICITY; PSEUDOMEMBRANOUS COLITIS;

AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; COLECTOMY; COMMUNICABLE DISEASES, EMERGING; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INCIDENCE; INFECTION CONTROL; METRONIDAZOLE; RISK FACTORS; VANCOMYCIN;

EID: 53449091591     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Wanahita A, Goldsmith E, Marino B, Musher D. Clostridium difficile infection in patients with unexplained leukocytosis. Am J Med. 2003;115:543-546.
2. Dubberke E, Reske K, Olsen M, McDonald L, Fraser V. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis. 2008;46:497-504.
3. Lawrence S, Puzniak L, Shadel B, et al. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007;28(2):123-130.
4. Kyne L, Hamel M, Polavaram R, Kelly C. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346-353.
5. McDonald L, Owings M, Jernigan D. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis. 2006;12(3):409-415.
6. Loo V, Poirier L, Miller M, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005; 353:2442-2449.
7. Mooney H. Annual incidence of MRSA falls in England, but Clostridium difficile continues to rise. BMJ. 2007;335(7627):958.
8. Muto C, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26(3):273-280.
9. Pépin J, Valiquette L, Cossette B. Mortality attibutable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173(9).
10. Layton B, McDonald L, Gerding D, Liedtke L, Strausbaugh L. IDSA Emerging Infections Network. Perceived increases in incidence and severity of Clostridium difficile disease: an emerging threat that continues to unfold. 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Los Angeles, CA April 9-12, 2005 Abstract 66 2005.
11. McDonald L, Killgore G, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-2441.
12. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005; 366(9491):1079.
13. Bobulsky G, Al-Nassir W, Riggs M, Sethi A, Donskey C. Clostridium difficile skin contamination in patients with C difficile-associated disease. Clin Infect Dis. 2008;46:447-450.
14. Dubberke E, Reske K, Noble-Wang J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control. 2007;35(5):315-318.
15. McFarland L, Mulligan M, Kwok R, Stamm W. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204-210.
16. Riggs M, Sethi A, Zabarsky T, Eckstein E, Jump R, Donskey C. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45:992-998.
17. Gaynes R, Rimland D, Killum E, et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis. 2004;38:640-645.
18. Pépin J, Saheb N, Coulombe M, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254-1260.
19. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004;171(1):33-38.
20. Dial S, Delaney J, Barkun A, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294(23):2989-2995.
21. Redelings M, Sorvillo F, Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis. 2007;13(9):1417-1419.
22. Kyne L, Warny M, Qamar A, Kelly C. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342(6):390-397.
23. Kyne L, Warny M, Sethi A. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet. 2001;357(9251):189-193.
24. Bassaris H, Lianou P, Legakis N, Papavassiliou J. Interaction between Clostridium difficile and polymorphonuclear leucocytes from the elderly and post-operative cancer patients: phagocytosis and bactericidal function. Med Microbiol Immunol. 1984;173(1):49-55.
25. Bartlett J, Gerding D. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):S12-S18.
26. Ticehurst J, Aird D, Dam L, Borek A, Hargrove J, Carroll K. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44(3):1145-1149.
27. Zar F, Bakkanagari S, Moorthi K, Davis M. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile- associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302-307.
28. Gerding D, Muto C, Owens R. Treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):S32-S42.
29. Apisarnthanarak A, Razavi B, Mundy L. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis. 2002;35:690-696.
30. Aas J, Gessert C, Bakken J. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36:580-585.
31. Lamontagne F, Labbé A, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245:267-272.
32. Byrn J, Maun D, Gingold D, Baril D, Ozao J, Divino C. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150-154.
33. Fawley W, Underwood S, Freeman J, et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol. 2007;28(8):920-925.
34. Mayfield J, Leet T, Miller J, Mundy L. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31:995-1000.
35. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR. 2002;51(RR-16):1-45.
36. Siegel J, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Isolation2007.pdf, 70. 2007.
37. Simor A, Bradley S, Strausbaugh L, Crossley K, Nicolle L. The SHEA Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol. 2002;23(11):696-703.